BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, published by Wiley, is a renowned journal that bridges the gap between fundamental research and practical applications in the fields of biochemistry and biotechnology. With an ISSN of 0885-4513 and an E-ISSN of 1470-8744, this journal has been instrumental since its inception in 1986, focusing on diverse topics including applied microbiology, drug discovery, and process chemistry. The journal is currently recognized in various categories with impressive quartile rankings, showcasing its influence with placements in Q2 for applied microbiology, biotechnology, and biomedical engineering, among others. Researchers and professionals benefit from its comprehensive scope and critical insights into the latest advancements in these domains. Although not an open-access journal, it provides invaluable access options for academic institutions and professionals seeking to stay at the forefront of biotechnology innovations. Its commitment to presenting quality research facilitates the growth of knowledge and fosters collaborations across disciplines, making it an essential resource for anyone invested in the rapidly evolving landscape of biosciences.

BIOTECHNOLOGY ADVANCES is a premier, peer-reviewed journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to advancing knowledge in the rapidly evolving fields of biotechnology and bioengineering. With an ISSN of 0734-9750 and an E-ISSN of 1873-1899, this esteemed journal covers a wide spectrum of topics relevant to applied microbiology, molecular biology, and biochemical innovation. Recognized for its academic rigor, it holds a distinguished position in the top quartile (Q1) in multiple categories, including Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology, further evidenced by its high rankings in Scopus, where it ranks #3/127 in Applied Microbiology and Biotechnology and #7/311 in Biotechnology. Researchers and professionals in the field value the journal not only for its comprehensive coverage of cutting-edge research but also for its commitment to disseminating critical findings and fostering collaboration. While BIOTECHNOLOGY ADVANCES currently operates under a subscription model, its potential impact on future innovations in biotechnology cannot be overstated, making it an essential resource for anyone interested in the forefront of biotechnological advancements.

Synthetic and Systems Biotechnology, published by KEAI PUBLISHING LTD, is a pioneering open-access journal that has made significant contributions to the fields of applied microbiology, biotechnology, biomedical engineering, genetics, and structural biology since its inception in 2016. With an ISSN of 2405-805X, this journal is committed to fostering innovative research and interdisciplinary collaboration, providing a platform for the dissemination of high-quality studies that push the boundaries of scientific knowledge. Recognized for its excellence, it holds prestigious Q1 rankings in both Applied Microbiology and Biotechnology as well as Biomedical Engineering in 2023, alongside notable Q2 rankings in Genetics and Structural Biology. Researchers, professionals, and students alike can access cutting-edge research that explores the dynamic interplay between synthetic biology and systems biology, driving advancements that could reshape health, industry, and environmental sustainability. By operating under an open-access model, Synthetic and Systems Biotechnology ensures that new findings are accessible to a global audience, thereby maximizing the impact and reach of the published work and paving the way for future discoveries.

Microbial Cell is a distinguished open-access journal published by SHARED SCIENCE PUBLISHERS OG, focusing on the dynamic fields of microbiology, biochemistry, and molecular biology. Since its establishment in 2014, Microbial Cell has been at the forefront of disseminating cutting-edge research essential for advancing our understanding of microbial functions and interactions. With a commendable impact factor and ranking in the top quartiles (Q1 and Q2) across several categories, including Applied Microbiology and Biotechnology and Parasitology, this journal serves as an invaluable resource for researchers, professionals, and students alike. It features a comprehensive scope that encompasses the latest findings in genetics, cell biology, and virology, facilitating the academic community's access to high-quality peer-reviewed work. Microbial Cell not only contributes to advancing microbial sciences but also fosters an inclusive platform for knowledge sharing and collaboration in the scientific community.

BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, published by the Korean Society for Biotechnology and Bioengineering, is a prominent journal in the fields of applied microbiology, biotechnology, bioengineering, and biomedical engineering. Since its inception in 1996, this journal has served as a vital platform for researchers and professionals, facilitating the dissemination of cutting-edge research and innovative applications related to bioprocesses and biotechnology systems. With an ISSN of 1226-8372, this journal is ranked within the Q3 quartile across several categories, demonstrating its relevance and impact in the academic community. Although it operates under traditional access modalities, the journal strives to provide quality and timely insights into the advancements in bioprocess technology and microbial applications, fostering a collaborative environment for knowledge exchange. Notably, it is indexed with a respectable presence on Scopus, making it a valuable resource for students and professionals seeking the latest developments in biotechnology. For more details, kindly refer to the Korean Science Technology Center, #704 Yeoksam-Dong, Gangnam-Ku, Seoul 135-703, South Korea.

NATURE BIOTECHNOLOGY, an esteemed journal published by NATURE PORTFOLIO, stands at the forefront of innovation in biotechnological research since its inception in 1989. With an impressive impact factor reflecting its preeminent status—ranked in the Q1 quartile across multiple categories including Applied Microbiology, Bioengineering, Biomedical Engineering, Biotechnology, and Molecular Medicine—this journal is a pivotal resource for researchers and professionals aiming to advance the boundaries of biotechnology. The journal is highly regarded, boasting Scopus rankings in the 99th percentile within its categories. NATURE BIOTECHNOLOGY provides a platform for disseminating cutting-edge findings, with open access options that enhance the visibility and accessibility of its content to a global audience. The scope of the journal encapsulates a diverse range of topics from genetic engineering to pharmaceutical developments, ensuring comprehensive coverage of emerging biotechnological advances. As the field continues to evolve, NATURE BIOTECHNOLOGY remains committed to publishing groundbreaking research that shapes the future of science and industry.

BIOTECHNOLOGY LETTERS is a prestigious peer-reviewed journal that has been at the forefront of biotechnology research since its inception in 1979. Published by Springer, this esteemed journal serves as a vital platform for disseminating cutting-edge research in the fields of applied microbiology, bioengineering, and biotechnology, with a focus on innovative methodologies and technologies. With an impact factor reflecting its critical contribution to the discipline, BIOTECHNOLOGY LETTERS resides in the Q2 and Q3 tiers of various scientific categories, placing it among the notable journals in the biotechnological landscape. Although it offers traditional access options and does not feature open access, the journal embraces a global readership, encouraging submissions from researchers, professionals, and students eager to explore the dynamic advancements in biotechnology. Situated in the Netherlands, it continues to shape the future of the field through relevant, impactful research that addresses contemporary challenges and opportunities in medicine and beyond.

BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT is a leading open access journal published by TAYLOR & FRANCIS LTD from the United Kingdom, dedicated to advancing the field of biotechnology since its inception in 1990. Committed to disseminating high-quality research, the journal has transitioned to open access since 2014, enhancing its accessibility for researchers, professionals, and students alike. With a notable impact in the field, it is categorized in the Q3 quartile for Biotechnology as of 2023 and ranks #193 out of 311 in the Scopus categories for Biochemistry, Genetics, and Molecular Biology. The journal aims to cover a diverse range of topics related to both biotechnological advancements and the equipment that supports them, thus fostering innovative research and practical applications in the biotechnology sector. With an evolving scope that reflects the dynamic nature of biological research, BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT plays a crucial role in bridging the gap between laboratory studies and real-world applications, making it an essential resource for anyone involved in biotechnology research.

PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, published by Taylor & Francis Inc, serves as a vital platform for advancing research in the fields of biochemistry, biotechnology, and related areas of medicine. With an ISSN of 1082-6068 and an E-ISSN of 1532-2297, this journal has established itself with a notable Q3 ranking in the 2023 categories of Biochemistry, Biotechnology, and Miscellaneous Medicine, reflecting its relevance and contribution to these disciplines. The journal encompasses a wide range of topics, providing crucial insights into preparative methods, innovative biotechnological applications, and their implications for various medical advancements. Although not open access, the journal's rich content is crucial for researchers and professionals aiming to stay abreast of the latest developments and methodologies in biochemistry and biotechnology. With an enduring commitment to excellence since its inception in 1996, the journal remains an essential resource for academics and practitioners dedicated to advancing scientific knowledge and practical applications.

CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.